У нас вы можете посмотреть бесплатно Expanding Access to Screening May Help Prevent Esophageal Cancer или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Before the introduction of minimally invasive approaches, such as EsoGuard, used to screen for Barrett’s esophagus, endoscopy was the only option for patients — an invasive procedure that requires sedation, time off work and insurance coverage, which can limit access, according to Dr. Seper Dezfoli. Minimally invasive approaches, however, offer a more efficient, cost-effective alternative that could dramatically change how Barrett’s is detected and monitored. Identifying Barrett’s earlier is key, as 90% of patients diagnosed with esophageal cancer were never previously told they had Barrett’s. With broader use of EsoGuard, clinicians could screen more patients, intervene earlier and potentially prevent many cases of cancer. CURE sat down with Dezfoli to discuss how the noninvasive EsoGuard test could expand access to screening for Barrett’s esophagus and help prevent esophageal cancer. Dezfoli is a gastroenterologist and is board-certified in liver disease and medical weight management at ProHealth Partners, a Medical Group, Inc. View more at http://curetoday.com/ Or visit our socials! / curetoday / curemagazine / cure-media-group https://x.com/cure_today/ CURE has become the largest consumer magazine in the United States, focusing entirely on cancer. With a total circulation of 285,000, individual subscribers account for over 140,000 of that figure, with the remainder including cancer centers and advocacy groups around the country. CURE’s time-tested approach combines science, humanity and technology to make cancer understandable for patients and their caregivers.